Patients with ocular adverse events ≥2% in either group, safety population
| Adverse event (preferred term), n (%) | Bimatoprost PF (N=301) | Bimatoprost (N=295) |
|---|---|---|
| Conjunctival hyperaemia | 72 (23.9) | 77 (26.1) |
| Mild | 53 (17.6) | 62 (21.0) |
| Moderate | 19 (6.3) | 13 (4.4) |
| Severe | 0 (0.0) | 2 (0.7) |
| Eye pruritus | 12 (4.0) | 12 (4.1) |
| Punctate keratitis | 9 (3.0) | 9 (3.1) |
| Foreign body sensation in eyes | 7 (2.3) | 2 (0.7) |
| Dry eye | 5 (1.7) | 9 (3.1) |
PF, preservative-free.